tiprankstipranks
Trending News
More News >
Dassault Systemes S.A. (ADR) (DASTY)
:DASTY
Advertisement

Dassault Systemes SA (DASTY) AI Stock Analysis

Compare
229 Followers

Top Page

DASTY

Dassault Systemes SA

(OTC:DASTY)

Select Model
Select Model
Select Model
Outperform 71 (OpenAI - 4o)
Rating:71Outperform
Price Target:
$34.00
▼(-3.22% Downside)
Dassault Systemes SA's overall stock score reflects its strong financial performance, particularly in revenue growth and profitability, despite some operational efficiency concerns. The technical analysis suggests a bearish trend, but potential for reversal exists. The valuation indicates the stock is relatively expensive, though the dividend yield offers some compensation. The earnings call sentiment is slightly positive, with notable strengths in subscription growth and contract wins, balanced by challenges in certain segments.

Dassault Systemes SA (DASTY) vs. SPDR S&P 500 ETF (SPY)

Dassault Systemes SA Business Overview & Revenue Model

Company DescriptionDassault Systèmes SE is a leading global provider of 3D design, 3D digital mock-up, and product lifecycle management (PLM) software. Founded in 1981 and headquartered in Vélizy-Villacoublay, France, the company serves a wide range of industries including aerospace, automotive, consumer goods, and life sciences. Its core products include the 3DEXPERIENCE platform, CATIA, SOLIDWORKS, and ENOVIA, which enable companies to create, simulate, and manage the entire lifecycle of their products from design to manufacturing and maintenance.
How the Company Makes MoneyDassault Systèmes generates revenue primarily through software licenses, subscription services, and maintenance agreements. The company offers various licensing models, including perpetual licenses and subscription-based SaaS solutions, which provide recurring revenue streams. Key revenue streams include the sale of software licenses for its flagship products like CATIA and SOLIDWORKS, as well as subscription services for its cloud-based offerings on the 3DEXPERIENCE platform. Additionally, the company earns income from maintenance and support services for its software products. Significant partnerships with major companies in industries such as aerospace and automotive further enhance its revenue opportunities, as customers often integrate Dassault Systèmes' solutions into their operations to improve design and manufacturing processes.

Dassault Systemes SA Earnings Call Summary

Earnings Call Date:Oct 23, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 11, 2026
Earnings Call Sentiment Neutral
The earnings call highlighted strong subscription growth and significant contract wins, particularly in the Industrial segment, indicating a positive trend towards subscription and cloud solutions. However, challenges in the Life Sciences segment and lower growth from MEDIDATA and Centric, along with cash flow conversion concerns, present notable challenges. Overall, the sentiment is slightly positive but tempered by these challenges.
Q3-2025 Updates
Positive Updates
Subscription Revenue Growth
Subscription revenue grew by 16%, now accounting for almost half of the recurring revenue base, up from 1/3 a few years ago.
Operating Margin Achievement
Achieved a 30.1% operating margin, reflecting strong focus on running a profitable and efficient business.
Significant Contract Wins
Signed major contracts with Ford and Stellantis, expanding the use of the 3DEXPERIENCE platform.
AI and Cloud Growth
3DEXPERIENCE cloud revenue grew 36% in the quarter, indicating strong market adoption of AI and cloud solutions.
Industrial Innovation Segment Performance
Industrial Innovation segment delivered a 9% growth in the quarter, driven by the 3DEXPERIENCE platform.
Negative Updates
MEDIDATA Revenue Decline
Life Sciences growth was down 3% in the third quarter, with MEDIDATA impacted by a decline in clinical trial starts.
Centric Growth Challenges
Centric growth was slower than expected due to some shifted renewals and the transition to a SaaS model.
Upfront License Revenue Decline
Upfront license revenue declined by 13% as clients continue to adopt the subscription model at an increasing rate.
Cash Flow Conversion Concerns
Operating cash flow decreased with a cash conversion rate expected at 78% to 80% for the full year 2025.
Company Guidance
During the call, Dassault Systèmes provided guidance for the remainder of 2025, highlighting several key metrics. The company reaffirmed its earnings guidance, expecting EPS to grow between 7% to 10%, with total revenue rising 4% to 6% on an adjusted basis. This growth is attributed to strong performance in their subscription business, which increased by 16%, and a focus on recurring revenue, which now makes up 84% of total software revenue. The operating margin for Q3 was reported at 30.1%, reflecting a 100 basis point increase, and EPS grew by 10% to EUR 0.29. The company also noted a solid performance in Industrial Innovations, particularly in the Transportation & Mobility sector, which grew by 18%, and highlighted successful contracts with major clients like Ford and Stellantis. Despite challenges in the Life Sciences sector, the company remains optimistic about its strategic focus on accelerating SaaS adoption and leveraging AI capabilities.

Dassault Systemes SA Financial Statement Overview

Summary
Dassault Systemes SA shows strong financial health with impressive revenue growth and profitability. The balance sheet is robust with effective leverage management, while cash flow generation remains solid despite a recent decline in free cash flow growth. The company is well-positioned in the software application industry, but attention should be given to maintaining operational efficiency and cash flow stability.
Income Statement
85
Very Positive
Dassault Systemes SA demonstrates strong revenue growth with a TTM (Trailing-Twelve-Months) revenue growth rate of 41.2%, indicating robust expansion. The company maintains high profitability with a gross profit margin of 82.05% and a net profit margin of 17.99% in the TTM period. However, there is a slight decline in EBIT margin from 23.5% in 2022 to 22.45% in the TTM period, which could indicate rising operational costs.
Balance Sheet
78
Positive
The balance sheet reflects a healthy financial position with a debt-to-equity ratio of 0.315 in the TTM period, showing effective leverage management. Return on equity remains stable at 13.29%, indicating efficient use of equity capital. The equity ratio is strong, suggesting a solid asset base. However, the decrease in total debt from previous years suggests a strategic reduction in leverage.
Cash Flow
72
Positive
Cash flow analysis reveals a slight decline in free cash flow growth by 7.07% in the TTM period, which could be a concern. The operating cash flow to net income ratio is 0.50, indicating moderate cash generation relative to net income. The free cash flow to net income ratio remains strong at 89.21%, suggesting efficient cash conversion.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue6.31B6.21B5.95B5.67B4.86B4.45B
Gross Profit5.27B5.20B4.98B4.75B4.07B3.70B
EBITDA1.94B1.92B1.81B1.94B1.61B1.29B
Net Income1.14B1.20B1.05B931.50M773.70M491.00M
Balance Sheet
Total Assets14.42B15.55B14.62B14.26B14.22B12.96B
Cash, Cash Equivalents and Short-Term Investments4.08B3.95B3.57B2.77B2.98B2.15B
Total Debt2.58B3.06B3.60B3.58B4.47B4.83B
Total Liabilities6.22B6.47B6.78B6.94B8.01B7.86B
Stockholders Equity8.18B9.07B7.83B7.31B6.20B5.06B
Cash Flow
Free Cash Flow1.50B1.47B1.42B1.39B1.51B1.11B
Operating Cash Flow1.68B1.66B1.57B1.53B1.61B1.24B
Investing Cash Flow-424.20M-191.70M-161.60M-213.90M-160.40M-208.00M
Financing Cash Flow-1.00B-1.21B-536.70M-1.59B-711.90M-741.90M

Dassault Systemes SA Technical Analysis

Technical Analysis Sentiment
Negative
Last Price35.13
Price Trends
50DMA
32.09
Negative
100DMA
33.31
Negative
200DMA
36.14
Negative
Market Momentum
MACD
-1.47
Positive
RSI
23.11
Positive
STOCH
0.06
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DASTY, the sentiment is Negative. The current price of 35.13 is above the 20-day moving average (MA) of 31.36, above the 50-day MA of 32.09, and below the 200-day MA of 36.14, indicating a bearish trend. The MACD of -1.47 indicates Positive momentum. The RSI at 23.11 is Positive, neither overbought nor oversold. The STOCH value of 0.06 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DASTY.

Dassault Systemes SA Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
$23.00B45.2715.71%11.42%72.60%
73
Outperform
$64.08B62.3840.20%13.99%-0.95%
72
Outperform
$62.34B107.976.66%14.21%-62.56%
71
Outperform
$37.00B28.2013.80%1.09%5.22%6.27%
70
Outperform
$38.55B62.8216.66%34.26%
68
Neutral
$14.86B62.5523.69%0.56%10.45%-32.43%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DASTY
Dassault Systemes SA
27.53
-6.53
-19.17%
ADSK
Autodesk
300.96
-1.37
-0.45%
FICO
Fair Isaac
1,629.20
-461.43
-22.07%
WDAY
Workday
232.10
-19.70
-7.82%
PTC
PTC
189.97
-8.07
-4.07%
BSY
Bentley Systems
48.48
-1.18
-2.38%

Dassault Systemes SA Corporate Events

Dassault Systèmes Reports Strong Q3 2025 Performance
Oct 24, 2025

Dassault Systèmes S.A. (ADR) is a leading software company specializing in 3D design, 3D digital mock-up, and product lifecycle management solutions, primarily serving industries such as manufacturing, life sciences, and infrastructure.

Dassault Systèmes Earnings Call: Subscription Growth Shines
Oct 24, 2025

Dassault Systèmes S.A. (ADR) recently held its earnings call, revealing a slightly positive sentiment among investors and analysts. The company showcased impressive subscription growth and significant contract wins, particularly in the Industrial segment, which signals a positive trend towards subscription and cloud solutions. However, challenges in the Life Sciences segment, alongside lower growth from MEDIDATA and Centric, as well as concerns regarding cash flow conversion, have tempered the overall enthusiasm.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 24, 2025